Molecular targeted drug therapy of cervical cancer / 国际肿瘤学杂志
Journal of International Oncology
; (12): 548-551, 2016.
Article
en Zh
| WPRIM
| ID: wpr-494854
Biblioteca responsable:
WPRO
ABSTRACT
Advanced and recurrent cervical cancer has a poor prognosis and few effective therapeutic option.With the development of molecular biology,the targeted drugs for patients with locally advanced cervical cancer continuously appear,such as inhibiting human papillomavirus,targeting angiogenesis,epidermal growth factor receptor,mammalian target of rapamycin,cyclooxygenase-2,sarcoma gene,proteasome inhibitor,DNA methylation,etc.With the development of new molecular targeted therapy,more effective or even treatment measures of cervical cancer might be found,which can provid a new approach for the individualized treatment of cervical cancer.
Texto completo:
1
Índice:
WPRIM
Tipo de estudio:
Prognostic_studies
Idioma:
Zh
Revista:
Journal of International Oncology
Año:
2016
Tipo del documento:
Article